Brendan SIEOW

Published by Biotech Connection Singapore on

Brendan holds a PhD in synthetic biology and cancer immunotherapy from the National University of Singapore (NUS) and a B. Eng (1st Class Hons) from Nanyang Technological University (NTU). Prior to his PhD training, Brendan worked as a Member of Technical Staff in the Defence Medical and Environmental Research Institute @ DSO National Laboratories. 

As the 6th President of BCS, Brendan worked closely with public and private partners across the Singapore biotech ecosystem to support their strategic objectives and expand their reach. He is deeply passionate about advocating for researchers and bio-entrepreneurs, and about building pathways that enable the translation and commercialisation of scientific innovation.

Brendan is currently at NUS Yong Loo Lin School of Medicine, focused on developing and commercializing novel cancer therapeutics built during his PhD. His work spans intellectual property generation, strategic partnerships, and securing translational funding to bring the developed therapeutic assets out of the lab and into clinical development. He is currently in the process of building a venture in National GRIP Run 3.

In his free time, Brendan enjoys traveling, reading and having an active lifestyle with his wife and dog.

Biotech Connection Singapore (BCS) is part of an international network of non-profit organizations, that aims to promote the transfer of ideas from theory to real world applications by providing a platform for fostering interaction between academia, industry and businesses.